Skip to main content
construction release_alert
Scholars@Duke will be undergoing maintenance April 11-15. Some features may be unavailable during this time.
cancel
Journal cover image

Rheumatologists' knowledge of contraception, teratogens, and pregnancy risks.

Publication ,  Journal Article
Clowse, ME; Eudy, AM; Revels, J; Sanders, GD; Criscione-Schreiber, L
Published in: Obstet Med
December 2018

INTRODUCTION: Rheumatologists are essential partners in planning and managing pregnancies in women with lupus. Whether they know the essentials of contraceptive and medical treatment in pregnancy, however, is unknown. METHOD: Anonymous in-lecture surveys were completed by 270 rheumatologists to assess knowledge of contraceptive effectiveness, emergency contraception, medication teratogenicity, and lupus pregnancy risk assessment. RESULTS: Rheumatologists knew the high effectiveness of the intrauterine device, but over-estimated the effectiveness of injectable medroxyprogesterone and condoms. Almost all identified methotrexate as a teratogen, but only 69% identified cyclophosphamide and 37% mycophenolate. Most rheumatologists knew that lupus activity in pregnancy is the main predictor of pregnancy outcomes, but underestimated the risks of hypertension and race. CONCLUSION: To improve lupus pregnancy planning and management, rheumatologists would benefit from improved knowledge about contraceptive effectiveness, teratogens, and the risks from non-lupus factors for pregnancy complications.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Obstet Med

DOI

ISSN

1753-495X

Publication Date

December 2018

Volume

11

Issue

4

Start / End Page

182 / 185

Location

England

Related Subject Headings

  • 3215 Reproductive medicine
  • 1114 Paediatrics and Reproductive Medicine
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Clowse, M. E., Eudy, A. M., Revels, J., Sanders, G. D., & Criscione-Schreiber, L. (2018). Rheumatologists' knowledge of contraception, teratogens, and pregnancy risks. Obstet Med, 11(4), 182–185. https://doi.org/10.1177/1753495X18771266
Clowse, Megan Eb, Amanda M. Eudy, Jessica Revels, Gillian D. Sanders, and Lisa Criscione-Schreiber. “Rheumatologists' knowledge of contraception, teratogens, and pregnancy risks.Obstet Med 11, no. 4 (December 2018): 182–85. https://doi.org/10.1177/1753495X18771266.
Clowse ME, Eudy AM, Revels J, Sanders GD, Criscione-Schreiber L. Rheumatologists' knowledge of contraception, teratogens, and pregnancy risks. Obstet Med. 2018 Dec;11(4):182–5.
Clowse, Megan Eb, et al. “Rheumatologists' knowledge of contraception, teratogens, and pregnancy risks.Obstet Med, vol. 11, no. 4, Dec. 2018, pp. 182–85. Pubmed, doi:10.1177/1753495X18771266.
Clowse ME, Eudy AM, Revels J, Sanders GD, Criscione-Schreiber L. Rheumatologists' knowledge of contraception, teratogens, and pregnancy risks. Obstet Med. 2018 Dec;11(4):182–185.
Journal cover image

Published In

Obstet Med

DOI

ISSN

1753-495X

Publication Date

December 2018

Volume

11

Issue

4

Start / End Page

182 / 185

Location

England

Related Subject Headings

  • 3215 Reproductive medicine
  • 1114 Paediatrics and Reproductive Medicine